Court Overseeing Federal Testosterone Lawsuits Issues New Amended Order Governing Service of Process

Share Article

Bernstein Liebhard LLP is currently representing a number of testosterone lawsuit plaintiffs who have cases pending in the federal multidistrict litigation.

Free Case Review
We are pleased these lawsuits are progressing, and look forward to more progress in the weeks to come. Our attorneys will continue to closely monitor developments on behalf of our client.

The federal court overseeing hundreds of testosterone treatment lawsuits ( has amended its protocols governing Service of Process. Specifically, the Case Management Order issued on April 10th in the U.S. District Court, Northern District of Illinois, amends the manner in which plaintiffs may request a waiver of service from certain defendants, including AbbVie, Inc. and Abbott Laboratories. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is representing a number of plaintiffs who have filed testosterone lawsuits in the Northern District of Illinois, where all federally-filed claims involving this class of medications have been consolidated for the purposes of coordinated pretrial proceedings. We are pleased these lawsuits are progressing, and look forward to more progress in the weeks to come. Our attorneys will continue to closely monitor developments on behalf of our clients,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone treatments.

Testosterone Treatment Litigation

Currently, more than 1,100 testosterone treatment lawsuits are pending in the federal multidistrict litigation underway in Illinois, all of which were filed on behalf of men who allegedly suffered heart attacks, strokes, blood clots and other dangerous cardiovascular events related to the use of prescription testosterone replacement therapies. These plaintiffs further allege that the drug’s manufacturers failed to provide adequate warnings about their serious heart risks, and wrongly marketed the medications as safe and effective remedies for low libido, weight gain, fatigue and other symptoms associated with age-related drops in testosterone. The complaints point out that the U.S. Food & Drug Administration (FDA) has only approved testosterone therapy for men who suffer from hypogonadism, a reduction in testosterone related to an underlying illness or injury.

According to court documents, the FDA began reviewing the cardiovascular risks associated with prescription testosterone medications in January 2014, after a few studies indicated the drugs were associated with an increased risk of heart attacks, strokes, and death in certain men.* In an updated safety alert issued on March 3rd, the agency announced that the drug’s labels would be modified to include information about a possible link to heart attacks and strokes, and to clarify their approved uses. The FDA voiced concern that the drugs were increasingly being used to treat age-related symptoms in men, even though they have never been shown to be safe or effective for this purpose.

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website